ONEMEDNET CORPORATION Selling and Marketing Expense
ONEMEDNET CORPORATION (ONMD) reported Selling and Marketing Expense of $391.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-14
- ONEMEDNET CORPORATION selling and marketing expense for the quarter ending 2026-06-30 was $391.00K, a 52.14% increase year-over-year.
- ONEMEDNET CORPORATION selling and marketing expense for the quarter ending 2026-03-31 was $378.00K, a 30.34% increase year-over-year.
- ONEMEDNET CORPORATION selling and marketing expense for the quarter ending 2025-12-31 was $426.00K, a 105.80% increase year-over-year.
- ONEMEDNET CORPORATION selling and marketing expense for the quarter ending 2025-09-30 was $304.00K, a 117.14% increase year-over-year.
- ONEMEDNET CORPORATION selling and marketing expense for fiscal 2023 was $1.11M, a 16.39% increase from fiscal 2022.
- ONEMEDNET CORPORATION selling and marketing expense for fiscal 2022 was $958.00K.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $391.00K 10-Q · filed 2026-08-14 | $769.00K 10-Q · filed 2026-08-14 | $1.20M derived: sum of 3 quarters · filed 2026-08-14 | $1.50M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $378.00K S-1/A · filed 2026-07-08 | $804.00K derived: sum of 2 quarters · filed 2026-07-08 | $1.11M derived: sum of 3 quarters · filed 2026-07-08 | $1.36M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $426.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $730.00K derived: sum of 2 quarters · filed 2026-07-08 | $987.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.27M S-1/A · filed 2026-07-08 | |||
| 2025-09-30 | $304.00K 10-Q · filed 2025-11-14 | $561.00K derived: sum of 2 quarters · filed 2026-08-14 | $846.00K 10-Q · filed 2025-11-14 | $1.06M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $257.00K 10-Q · filed 2026-08-14 | $542.00K 10-Q · filed 2026-08-14 | $754.00K derived: sum of 3 quarters · filed 2026-08-14 | $894.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $290.00K S-1/A · filed 2026-07-08 | $497.00K derived: sum of 2 quarters · filed 2026-07-08 | $637.00K derived: sum of 3 quarters · filed 2026-07-08 | $890.00K derived: sum of 4 quarters · filed 2026-07-08 | |||
| 2024-12-31 | $207.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $347.00K derived: sum of 2 quarters · filed 2026-07-08 | $600.00K derived: sum of 3 quarters · filed 2026-07-08 | $830.00K S-1/A · filed 2026-07-08 | |||
| 2024-09-30 | $140.00K 10-Q · filed 2025-11-14 | $393.00K derived: sum of 2 quarters · filed 2025-11-14 | $623.00K 10-Q · filed 2025-11-14 | $924.00K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $253.00K 10-Q · filed 2025-08-13 | $483.00K 10-Q · filed 2025-08-13 | $784.00K derived: sum of 3 quarters · filed 2025-08-13 | $1.03M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | $229.00K 10-Q · filed 2025-05-14 | $531.00K derived: sum of 2 quarters · filed 2025-05-14 | $774.00K derived: sum of 3 quarters · filed 2025-05-14 | $1.08M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $302.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $545.00K derived: sum of 2 quarters · filed 2025-04-15 | $856.00K derived: sum of 3 quarters · filed 2025-04-15 | $1.11M 10-K · filed 2025-04-15 | $1.11M 10-K · filed 2024-04-09 | ||
| 2023-09-30 | $243.00K 10-Q · filed 2024-12-17 | $246.00K 8-K/A · filed 2024-11-22 | $554.00K derived: sum of 2 quarters · filed 2024-12-17 | $813.00K 10-Q · filed 2024-12-17 | $816.80K 10-Q · filed 2023-11-20 | $1.18M derived: sum of 4 quarters · filed 2024-12-17 | |
| 2023-06-30 | $311.00K 10-Q · filed 2024-12-11 | $571.00K 10-Q · filed 2024-12-11 | $940.00K derived: sum of 3 quarters · filed 2024-12-11 | $1.20M derived: sum of 4 quarters · filed 2024-12-11 | |||
| 2023-03-31 | $259.00K 10-Q · filed 2024-12-05 | $629.00K derived: sum of 2 quarters · filed 2024-12-05 | $886.00K derived: sum of 3 quarters · filed 2024-12-05 | ||||
| 2022-12-31 | $370.00K derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | $627.00K derived: sum of 2 quarters · filed 2024-11-22 | $958.00K 10-K/A · filed 2024-11-05 | $957.69K 10-K · filed 2024-04-09 | |||
| 2022-09-30 | $257.00K 8-K/A · filed 2024-11-22 | $588.00K 8-K/A · filed 2024-11-22 | $588.29K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |